A knee that feels stiff after sitting for a long time or aches on the stairs can make everyday activities surprisingly difficult. For people living with osteoarthritis, these problems can become a regular part of life as the protective cartilage inside their joints gradually wears down.
Cartilage helps bones move smoothly against one another. Unlike skin, however, this tissue has a limited ability to repair itself once significant damage occurs. Current treatments can ease pain and improve mobility, but they cannot reliably restore lost joint cartilage.
Now, research led by scientists at Stanford Medicine has raised an intriguing possibility: perhaps the body’s existing cartilage cells can be encouraged to repair damaged tissue by changing the signals that control how they behave.
The study, published in Science, focused on an enzyme called 15-PGDH. In experiments involving mice and human cartilage samples, blocking this enzyme produced encouraging signs of cartilage regeneration. The findings could eventually help shape new treatments for osteoarthritis, although much more research is needed before the approach can be offered to patients. (Stanford Medicine)
Why cartilage is so difficult to repair
Osteoarthritis is more than ordinary wear and tear. It is a joint disease involving changes to cartilage, the underlying bone and other tissues around the joint. Pain, swelling and stiffness can gradually interfere with walking, exercise and daily routines.
Articular cartilage has no direct blood supply, which limits its natural healing capacity. Its specialised cells, called chondrocytes, maintain a supportive network of proteins and other molecules that gives the tissue its strength, resilience and smooth surface.
When this network breaks down, the joint cannot easily rebuild it. Treatment therefore focuses on managing symptoms and maintaining function through approaches such as appropriate exercise, physiotherapy, medication when suitable and, in some cases, joint replacement surgery.
Scientists have long been interested in whether existing cartilage cells could be persuaded to restore more of this protective tissue.
The enzyme researchers are targeting
The Stanford team investigated 15-hydroxyprostaglandin dehydrogenase, usually shortened to 15-PGDH. This enzyme breaks down prostaglandin E2, a signalling molecule involved in several processes throughout the body.
The researchers found higher levels of 15-PGDH in the cartilage of older mice and in animal models of joint injury. They then tested whether blocking the enzyme could change how cartilage cells behaved.
The results were promising. In aged mice, treatment with a small-molecule 15-PGDH inhibitor led to thicker cartilage across the joint surface. The regenerated tissue showed features of hyaline cartilage, the specialised cartilage that normally covers the ends of bones in healthy joints.
Rather than relying on newly introduced stem cells, the process appeared to involve existing cartilage cells changing their gene activity and becoming better able to produce components of the surrounding tissue.
Researchers also tested the approach in mice with joint injuries. The treated animals showed less cartilage degeneration and improvements in measures of movement and joint function compared with untreated animals.
These results suggest that cartilage cells may retain more repair potential than scientists previously understood.
What did the researchers find in human tissue?
The study also included an important step beyond animal experiments: researchers examined cartilage samples removed from people undergoing knee replacement surgery.
When these samples were treated with the inhibitor in the laboratory, the team observed changes in gene activity associated with reduced cartilage breakdown and renewed production of cartilage-related components.
This is an encouraging finding because it suggests the biological pathway may also be relevant to human cartilage.
But there is an important distinction. Treating cartilage in a laboratory dish is not the same as regenerating a functioning knee inside a person. A living joint must withstand repeated loading, movement and pressure over many years. Researchers still need to establish whether the treatment can safely produce durable improvements in human joints.
The study does not show that people with osteoarthritis can currently regrow their cartilage with an injection or tablet.
Could this help prevent arthritis after a knee injury?
The findings may also matter for people who experience injuries such as an anterior cruciate ligament (ACL) tear. Even after an injury has been surgically repaired, some people develop osteoarthritis in the affected joint years later.
In the Stanford experiments, inhibiting 15-PGDH after joint injury reduced the development of cartilage damage in mice. This raises the possibility that future treatments could help protect joints during the period after an injury, when changes in the joint may contribute to long-term degeneration.
For now, this remains a research possibility rather than an established treatment. Further studies must determine which patients might benefit, when treatment would need to be given and whether any benefits last.
What can you do to protect your joints today?
While researchers work toward potential new therapies, there are practical ways to support joint health.
- Keep moving: Activities such as walking, swimming or cycling can help maintain mobility. Choose activities suited to your abilities and symptoms.
- Build muscle strength: Strengthening the muscles around the knee can improve support and everyday function. A physiotherapist can help tailor exercises to your needs.
- Manage persistent symptoms: Ongoing pain, swelling or stiffness deserves medical assessment, especially if it affects daily activities or follows an injury.
- Seek individualised advice: Treatments for osteoarthritis vary according to symptoms, health history and the severity of joint changes. A healthcare professional can help identify suitable options.
No particular food, supplement or exercise routine has been proven to regrow lost knee cartilage on its own.
A promising discovery, not a cure just yet
The Stanford research offers a fresh perspective on cartilage regeneration. By targeting 15-PGDH, scientists were able to stimulate meaningful repair responses in animal joints and observe encouraging changes in human cartilage samples.
That is a significant step in understanding how aging and injury affect joint tissue. However, the next challenge is to determine whether the approach can safely restore cartilage and improve pain and mobility in people.
For anyone living with osteoarthritis, the findings offer a reason for cautious optimism—not a reason to abandon existing care or seek unproven treatments.
The long-term goal is clear: move beyond simply managing joint damage and find ways to repair it. Whether blocking 15-PGDH can become part of that future will depend on the results of further research and carefully conducted human clinical trials.
Photo by Kindel Media: https://www.pexels.com/photo/a-person-holding-his-leg-7298631/